Vitrolife AB (publ) (VTRLY)

Market Cap	2.02B
Revenue (ttm)	372.37M
Net Income (ttm)	47.85M
Shares Out	n/a
EPS (ttm)	0.35
PE Ratio	42.29
Forward PE	33.59
Dividend	0.07 (0.46%)
Ex-Dividend Date	May 2, 2025

Volume	111
Average Volume	5
Open	14.20
Previous Close	15.00
Day's Range	14.20 - 15.00
52-Week Range	14.20 - 25.00
Beta	1.77
RSI	63.79
Earnings Date	Oct 23, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,169
• Stock Exchange: OTCMKTS
• Ticker Symbol: VTRLY

Financial Performance

Financial numbers in SEK